241
Participants
Start Date
July 31, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
June 30, 2014
Botulinum toxin type A
I.M. (in the muscle) injection on day 1 of a single treatment cycle.
Placebo
I.M. injection on day 1 of a single treatment cycle.
Cincinnati Children's Hospital Medical Center, Cincinnati
Children's Hospital of Michigan, Detroit
Gillette Children's Speciality Healthcare, Saint Paul
Rehabilitation Institute of Chicago, Chicago
Children's Hospital New Orleans, New Orleans
Texas Scottish Rite - Hospital for Children, Dallas
The Children's Hospital, Aurora
Shriner's Hospital for Children, Portland
Club De Leones Cruz Del Sur Rehabilitation Corporation, Punta Arenas, Punta Arenas
Dr Roberto Del Rio Hospital, Santiago
Neurorehabilitation Laboratory, Pontifical Catholic University, Santiago
CHU Jean Minjoz, Besançon
Hospital San José Celaya, Celaya
Centro de Rehabilitacion Infantil, Mexico City
Centro de Rehabilitacion Integral de Queretaro (CRIQ), Querétaro
Hospital Central Dr Ignacio Morones Prieto, San Luis Potosí City
Non-public Healthcare Unit at the Association for Disabled People KROK PO KROKU, Gdansk
B i L- Specjalistyczne Centrum Medyczne, Lodz
Non-public Healthcare Unit - Grunwaldzka Clinic, Poznan
Non-public Healthcare Unit Mazovian Neurorehabilitatio, Wiązowna
Ghulane Military Medical Academy and School of Medicine, Ankara
Ibn-i-Sina Hospital, Ankara
Yildirim Beyazit Training and Research Hospital, Ankara
GATA Haydarpasa Training Hospital, Istanbul
Istanbul Fizik Tedavi Rehabilitasyon Egitim ve Arastirma Hastanesi, Istanbul
Istanbul Fizik Tedavi Rehabilitasyon, Istanbul
Istanbul University Medical School, Istanbul
Dokuz Eylül University Medical Faculty, Izmir
Kocaeli University Medical Faculty, İzmit
Lead Sponsor
Ipsen
INDUSTRY